Skip to main content
. 2020 Dec;8(24):1712. doi: 10.21037/atm-20-3022a

Table 1. Prevalence of ARID1A mutations in different cancers.

Tumor origin Histologic subtype ARID1A mutations frequency References
Ovarian carcinoma clear cell (OCCC) ~60% (6,7,81)
endometrioid (EnOC) ~30%
Endometrial carcinoma endometrioid 29% (68,69,82)
clear cell 26%
serous 18%
Breast cancer (luminal types) 4–35% (33,78,79)
Hepatobiliary carcinoma 10–17% (75-77)
Pancreatic carcinoma 8–45% (70,71)
Gastric carcinoma 8–29% (72-74)